CorInnova, Inc.
CorInnova is developing a minimally invasive, non-blood contacting cardiac assist device aimed at treating acute heart failure. The device is designed to increase cardiac output, promote cardiac restoration, and reduce adverse events associated with traditional blood-contacting devices. Supported by significant investments and numerous awards, CorInnova is at the forefront of innovative heart failure treatment technology.
Industries
Nr. of Employees
small (1-50)
CorInnova, Inc.
Houston, Texas, United States, North America
Products
Minimally invasive non-blood-contacting cardiac assist implant
A collapsible, epicardial thin-film implant with internal conforming chambers and a self‑deploying frame that provides biventricular mechanical assistance via synchronized pneumatic inflation without contacting blood.
Minimally invasive non-blood-contacting cardiac assist implant
A collapsible, epicardial thin-film implant with internal conforming chambers and a self‑deploying frame that provides biventricular mechanical assistance via synchronized pneumatic inflation without contacting blood.
Services
Prototype development and benchtop testing
Design and fabrication of soft‑robotic thin‑film cardiac assist prototypes and execution of benchtop hemodynamic performance tests.
Preclinical large-animal studies and translational research
Execution of acute and chronic ovine heart-failure studies to evaluate deployment feasibility, safety, removability, hemocompatibility, and therapeutic effect.
Pneumatic driver and control system engineering
Design and oversight of pneumatic driver hardware and control algorithms to achieve cardiac-synchronized inflation of implant chambers.
Regulatory readiness and design control implementation
Conducting development and manufacturing activities within FDA- and CE-mandated medical device design control systems to support regulatory submissions.
Prototype development and benchtop testing
Design and fabrication of soft‑robotic thin‑film cardiac assist prototypes and execution of benchtop hemodynamic performance tests.
Preclinical large-animal studies and translational research
Execution of acute and chronic ovine heart-failure studies to evaluate deployment feasibility, safety, removability, hemocompatibility, and therapeutic effect.
Pneumatic driver and control system engineering
Design and oversight of pneumatic driver hardware and control algorithms to achieve cardiac-synchronized inflation of implant chambers.
Regulatory readiness and design control implementation
Conducting development and manufacturing activities within FDA- and CE-mandated medical device design control systems to support regulatory submissions.
Expertise Areas
- Minimally invasive cardiac assist device development
- Soft-robotic and thin-film implant engineering
- Preclinical large-animal cardiovascular testing
- Pneumatic actuation and cardiac-synchronized control systems
Key Technologies
- Soft-robotic direct cardiac compression
- Thin-film collapsible implant structures
- Minimally invasive self‑deploying delivery frames
- Pneumatic actuation synchronized to cardiac cycle